Article Covers Range of Opinions on Remdesivir Pricing
A recent STAT article offers the opinions of several experts on how much Gilead's COVID-19 treatment, remdesivir, should cost. While [...]
Cigna Offering Digital Support for Members with COVID-19
Health insurer Cigna is partnering with Collective Medical and Medocity to offer a new, real-time support tools to help members [...]
Prieto-Alhambra Talks RWE in Decision-Making During Pandemic
University of Oxford's Daniel Prieto-Alhambra in a recent interview with The Evidence Base discussed the role of real-world evidence amid [...]
ICER Appoints New Members to Independent Councils
The Institute for Clinical and Economic Review (ICER) announced new appointments to each of its three independence evidence appraisal councils. [...]
The Importance of Evidence Translation
While peer-reviewed journals are key for transmitting scientific knowledge to the public, it's important for experts to "translate" the evidence [...]
Research Considers Valuation of Indirect Benefits
The National Pharmaceutical Council (NPC) and RTI Health Solutions in research published earlier this year found the inclusion of indirect [...]
Winegarden: ICER’s Cost Model ‘Wrong,’ ‘Dangerous’
Wayne Winegarden, senior fellow in business and economics at the Pacific Research Institute, says the Institute for Clinical and Economic [...]
EMA Reportedly Preparing Q&A Guidance on Big Data
The European Medicines Agency (EMA) is reportedly preparing new guidance on the application of EU data rules for secondary use [...]
Experts: Including Productivity in Value Assessment Frameworks Can Make Difference
The National Pharmaceutical Council (NPC) in a recent study published in JAMA suggests including productivity in value assessments can have [...]
Free Webinar to Outline Ways to Boost Health Care Value
The Value Institute for Health and Care is set to host a free webinar outlining ways the health care industry [...]
Podcast Considers Insurance Costs for Self-Employed Insurers
Point6 Healthcare Assistant Vice President Brian Scott in a recent Relentless Health Value podcast discusses how self-insured employers can protect [...]
Reducing Market Access Risk: How Digital Technology is Strengthening Strategies
PRMA Consulting Product Owner of Digital Applications Dr. William Grandy in a recent tHEORetically Speaking blog post outlines how PRMA [...]
Studies Offer Insight into Coronavirus Deaths
Two recent studies suggest people dying of COVID-19 could have gone on to live for, on average, another decade, The [...]
Article: Health Jobs No Longer Recession Proof
While health care jobs have been generally considered recession-proof, the COVID-19 pandemic is breaking that trend, according to a recent [...]
ICER Outlines Alternative Models for Judging Price of COVID-19 Treatments
The Institute for Clinical and Economic Review (ICER) recently recommended two alternative models for judging the "fairness" of pricing for [...]
ICER’s Venable Focuses on Patient Engagement
Yvette Venable, the Institute for Clinical and Economic Review's (ICER) vice president of patient engagement, is working to foster stronger [...]
Vizient’s Vega Talks Medical Device Industry, Value in Healthcare
In a recent interview with Evidera's Ann Menzie, Vizient's Patrick Vega discussed a number of topics, including key trends in [...]
Patients as Partners U.S. Podcast Series
Patients as Partners U.S. has posted another installment in its podcast series highlighting last year's event. The series includes: Chief [...]
Blog Considers Cost of Flattening the Curve
A recent blog post on The Incidental Economist highlights the economic costs of the current shutdown spurred by COVID-19. The [...]
Evidera Blog Post Highlights Approach to Assessing Real-World Research Questions
A recent Evidera blog post highlights its systematic approach to the assessment of real-world research questions supported by digital enablement. [...]
Collecting Data in the Midst of a Pandemic
Evidera's Mariah Baltezegar in a recent blog post considers how to best collect data during the COVID-19 pandemic. Baltezegar writes [...]
Harvard Researchers Suggest Central Database to Fill Evidence Gaps
Harvard researchers in a recent article say a central database should be developed to help fill in precision medicine evidence [...]
Report Examines Potential of Real-World Clinicogenomic Data
A recent article published in Cancer Discovery considers the potential of real-world data on AKT1-mutant metastatic breast cancer. Researchers utilized [...]
Nexus 2020 Issues Call for Posters
The Academy of Managed Care Pharmacy (AMCP) is now accepting poster submissions as it gears up for the Nexus 2020 [...]
ICER: Remdesivir Cost-effective at $4,460
The Institute for Clinical and Economic Review (ICER) has established a starting point for discussion about the price of Gilead's [...]